Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”

Detalles Bibliográficos
Autores principales: Curtis, Helen, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162308/
https://www.ncbi.nlm.nih.gov/pubmed/30131547
http://dx.doi.org/10.1038/s41416-018-0226-3
_version_ 1783359116168658944
author Curtis, Helen
Goldacre, Ben
author_facet Curtis, Helen
Goldacre, Ben
author_sort Curtis, Helen
collection PubMed
description
format Online
Article
Text
id pubmed-6162308
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61623082019-08-28 Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis” Curtis, Helen Goldacre, Ben Br J Cancer Correspondence Nature Publishing Group UK 2018-08-21 2018-08-28 /pmc/articles/PMC6162308/ /pubmed/30131547 http://dx.doi.org/10.1038/s41416-018-0226-3 Text en © Cancer Research UK 2018 https://creativecommons.org/licenses/by-nc-sa/4.0/Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License.)
spellingShingle Correspondence
Curtis, Helen
Goldacre, Ben
Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title_full Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title_fullStr Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title_full_unstemmed Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title_short Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
title_sort reply to comment on ‘impact of nice guidance on tamoxifen prescribing in england 2011–2017: an interrupted time series analysis”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162308/
https://www.ncbi.nlm.nih.gov/pubmed/30131547
http://dx.doi.org/10.1038/s41416-018-0226-3
work_keys_str_mv AT curtishelen replytocommentonimpactofniceguidanceontamoxifenprescribinginengland20112017aninterruptedtimeseriesanalysis
AT goldacreben replytocommentonimpactofniceguidanceontamoxifenprescribinginengland20112017aninterruptedtimeseriesanalysis

Ejemplares similares